Skip to main content
O

OXYGENTA PHARMACEUTICAL LIMITED — Investor Relations & Filings

Ticker · 524636 ISIN · INE102E01018 LEI · 984500FB9E6H1072B907 BSE.NS Manufacturing
Filings indexed 0 across all filing types
Latest filing no filings yet
Country IN India
Listing BSE.NS 524636

About OXYGENTA PHARMACEUTICAL LIMITED

https://www.oxygentapharma.com

Oxygenta Pharmaceutical Limited focuses on the development, manufacturing, and commercialization of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. The company maintains a diverse product portfolio catering to various therapeutic segments, including anti-fungals, anti-infectives, and other specialty chemical applications. Utilizing modern manufacturing infrastructure, the organization adheres to rigorous quality control protocols to ensure compliance with global standards. Its core competencies include complex chemical synthesis, process optimization, and large-scale production capabilities. Oxygenta provides integrated solutions ranging from research and development to contract manufacturing services, supporting the requirements of global healthcare partners through technical expertise and scalable manufacturing processes.

Recent filings

No filings indexed yet

We are still gathering filings for OXYGENTA PHARMACEUTICAL LIMITED. .

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.